| Name | 3-(4-benzylpiperidin-1-yl)-1-(7-methoxy-3,5-dihydro-2H-1,4-benzothiazepin-4-yl)propan-1-one |
|---|---|
| Synonyms |
JTV-519 hemifumate
JTV 519 free base,JTV519 free base 1-(2,3-Dihydro-7-methoxy-1,4-benzothiazin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-1-propanone hemifumate 4-[3-(4-Benzylpiperidin-1-yl)propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazine JTV 519 1-(2,3-Dihydro-7-methoxy-1,4-benzothiazin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-1-propanone K201 4-[3-(4-Benzylpiperidin-1-yl)propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine K21 JTV-519 (K201 1-Propanone, 1-(2,3-dihydro-7-methoxy-1,4-benzothiazin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl] K201 hemifumate K201 free base UNII-EBY0ENK2GQ JTV-519 hemifumarate 3-(4-benzylpiperidin-1-yl)-1-(7-methoxy-2,3-dihydrobenzo[f][1,4]thiazin-4(5H)-yl)propan-1-one(K201 hemifumate) |
| Description | JTV-519 free base (K201 free base) is a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and a partial agonist of ryanodine receptors in striated muscle. Cardioprotective agent[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.153 g/cm3 |
|---|---|
| Boiling Point | 615.133ºC at 760 mmHg |
| Molecular Formula | C25H32N2O2S |
| Molecular Weight | 424.59900 |
| Flash Point | 325.821ºC |
| Exact Mass | 424.21800 |
| PSA | 58.08000 |
| LogP | 4.35010 |
|
~%
145903-06-6 |
| Literature: Marks, Andrew R.; Landry, Donald W.; Deng, Shi Xian; Cheng, Zhen Zhuang Patent: US2005/215540 A1, 2005 ; Location in patent: Page/Page column 37 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |